Markets:

Overview

News

Currencies

International

Treasuries

Medtronic (NY:MDT)

76.15 -1.81 (-2.32%)

Official Closing Price Updated: 7:00 PM EDT, May 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Medtronic

< Previous 1 2 3 4 5 6 7 8 9

...

46 47 Next >

3 Stocks With Monster Potential to Hold Through the Next Decade of Uncertainty ↗

Today 11:35 EDT

These three stocks are deeply unloved, giving them material upside, and they have great businesses.

Via The Motley Fool

Topics Economy

Why Savvy Investors Are Loading Up on This Beaten-Down Stock ↗

May 09, 2026

Medtronic is closing in on Dividend King status, and its surgical robot is gaining traction.

Via The Motley Fool

3 Healthcare Stocks Every Retiree Should Consider ↗

May 08, 2026

If you are trying to generate income in retirement, these three high-yield healthcare stocks could be the perfect fit for you.

Via The Motley Fool

Topics Intellectual Property Retirement

Medtronic PLC (NYSE:MDT): A Durable Dividend Stock for Income Investors ↗

April 09, 2026

Via Chartmill

Better Than Intuitive Surgical? 1 Under-the-Radar Healthcare Stock to Buy and Hold Forever ↗

May 08, 2026

Intuitive Surgical's success hints that this competitor could have more growth potential than investors think.

Via The Motley Fool

Topics Supply Chain

Medtronic Stock Outlook: Is Wall Street Bullish or Bearish?

May 06, 2026

Although Medtronic has lagged behind the S&P 500 Index over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Via Barchart.com

Topics ETFs Economy Stocks

Want to Collect a High Dividend Every Month? Invest in These 3 Stocks ↗

May 05, 2026

By holding these top income stocks in your portfolio, you can have a position in some great companies while also generating cash flow each month.

Via The Motley Fool

Topics Intellectual Property

3 Reasons Analysts Love DexCom ↗

May 05, 2026

Via MarketBeat

Got $1,000? Which of These Beaten-Down Healthcare Stocks Is Worth Buying? ↗

May 02, 2026

These longtime market beaters may not have peaked yet.

Via The Motley Fool

Topics World Trade

Top S&P500 movers in Wednesday's after hours session ↗

April 29, 2026

Via Chartmill

3 Healthcare Stocks That Pay You While You Wait for the Growth ↗

April 27, 2026

It may not seem like it at first, but these dividends are safe.

Via The Motley Fool

Topics Intellectual Property

Forget Neuralink: The Real Brain Tech Trade Has 10 Names You’ve Never Heard ↗

April 25, 2026

The real brain computer interface opportunity isn’t in the headlines. These 10 stocks are building the systems that make it possible.

Via InvestorPlace

Topics Artificial Intelligence Economy Initial Public Offering

3 Healthcare Stocks That Pay You a Dividend While You Wait for a Recovery ↗

April 25, 2026

As you wait for stock prices to rebound, these three healthcare companies pay dividends with generous yields.

Via The Motley Fool

Topics Intellectual Property World Trade

What You Need to Know Ahead of Medtronic's Earnings Release

April 24, 2026

Medtronic is expected to release its fiscal fourth-quarter earnings soon, and analysts project a single-digit profit drop.

Via Barchart.com

Topics ETFs

Intuitive Surgical's Selloff Sets Up a 30% Rebound Opportunity ↗

April 23, 2026

Via MarketBeat

Stock Market Today, April 22: Boston Scientific Jumps After Q1 Earnings Beat Resets Growth Expectations ↗

April 22, 2026

On April 22, 2026, investors weigh a rare combo of earnings strength and softer long-term targets reshaping this medtech leader’s outlook.

Via The Motley Fool

Topics Earnings Stocks

Could This Healthcare Stock Help Make You Rich Over the Next Decade? ↗

April 19, 2026

Intuitive Surgical has already made many of its early investors wealthy.

Via The Motley Fool

3 Magnificent Dividend Stocks the Sell-Off Has Put on Sale. Buy Them Now and Hold Forever. ↗

April 17, 2026

With these Dividend Kings, the market's pain is your gain.

Via The Motley Fool

J&J Shatters Estimates as Oncology and MedTech Power 2026 Outlook Higher

April 15, 2026

Johnson & Johnson (NYSE: JNJ) delivered a robust first-quarter 2026 earnings report on April 14, 2026, handily beating Wall Street expectations and signaling a successful navigation of the long-feared...

Via MarketMinute

Topics Economy Intellectual Property

Inflation Fever Breaks: March PPI Data Offers Unexpected Relief to Markets

April 15, 2026

The financial markets received a much-needed breath of fresh air this week as the Bureau of Labor Statistics released the Producer Price Index (PPI) report for March 2026. Final demand prices rose by...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Boston Scientific’s $14.9 Billion Bet: The Strategic "Homecoming" to Neurovascular Dominance

April 15, 2026

As of April 15, 2026, the medical technology landscape is bracing for its most significant transformation in years. Boston Scientific (NYSE:BSX) is moving steadily toward the finalization of its $14.9...

Via MarketMinute

Topics Economy

Consolidation Fever: Boston Scientific’s $14.9 Billion Bet on Penumbra Signals New Era in MedTech M&A

April 15, 2026

In a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (NYSE: BSX) announced its definitive agreement to acquire Penumbra, Inc. (NYSE: PEN) for approximately...

Via MarketMinute

Topics Economy

MedTech Surge and Oncology Resilience Drive Johnson & Johnson to Q1 Earnings Beat

April 14, 2026

In a resounding display of corporate resilience, Johnson & Johnson (NYSE:JNJ) reported first-quarter 2026 financial results that surpassed Wall Street expectations, signaling a successful navigation of...

Via MarketMinute

Topics Bankruptcy Earnings Economy

Johnson & Johnson Shatters Expectations in Q1 2026, Raising Full-Year Outlook as Healthcare Giant Pushes Toward $100 Billion Milestone

April 14, 2026

NEW BRUNSWICK, N.J. — In a powerful display of resilience and strategic execution, Johnson & Johnson (NYSE: JNJ) reported first-quarter 2026 financial results that exceeded Wall Street estimates across...

Via MarketMinute

Topics Economy Intellectual Property

The New J&J: A 2026 Deep Dive into the Global Healthcare Titan

April 14, 2026

As of April 14, 2026, Johnson & Johnson (NYSE: JNJ) stands as a radically different entity than it was only three years ago. Following the successful spin-off of its consumer health division, Kenvue,...

Via Finterra

Topics Artificial Intelligence Death Economy

The Teleflex Pivot: Inside the $1 Billion Share Buyback and Strategic Breakup

April 09, 2026

Disclaimer: This content is intended for informational purposes only and is not financial advice. Today’s date is April 9, 2026. Introduction In the high-stakes arena of medical technology, few stories...

Via Finterra

Topics Economy World Trade

3 Dividend Stocks to Double Up On Right Now ↗

April 08, 2026

From energy to healthcare, this trio of reliable dividend payers are worth a deep dive today.

Via The Motley Fool

Topics Economy

This Healthcare Stock Has No Debt and a Near-Monopoly in Its Market ↗

April 07, 2026

The company is a picture of financial stability.

Via The Motley Fool

Hologic, Inc. (NASDAQ: HOLX): A New Chapter as a Women’s Health Powerhouse

April 07, 2026

Today marks a definitive turning point for Hologic, Inc. (NASDAQ: HOLX). As the company prepares to finalize its $18.3 billion acquisition by private equity giants Blackstone and TPG, it stands as a...

Via Finterra

Topics Artificial Intelligence Retirement World Trade

Robotic Revolution in the Electrophysiology Lab: FDA Clears Stereotaxis Synchrony System

April 06, 2026

ST. LOUIS – April 6, 2026 – In a milestone that signals a paradigm shift for cardiac care, Stereotaxis (NYSE American: STXS) has received FDA 510(k) clearance for its Synchrony™ System. The approval...

Via MarketMinute

Topics Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9

...

46 47 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.